Literature DB >> 17947530

In vivo footprint of a picornavirus internal ribosome entry site reveals differences in accessibility to specific RNA structural elements.

Olga Fernández-Miragall1, Encarnación Martínez-Salas.   

Abstract

Internal ribosome entry site (IRES) elements were described in picornaviruses as an essential region of the viral RNA. Understanding of IRES function requires a detailed knowledge of each step involved in the internal initiation process, from RNA folding and IRES-protein interaction to ribosome recruitment. Thus, deciphering IRES accessibility to external agents due to RNA structural features, as well as RNA-protein protection within living cells, is of primary importance. In this study, two chemical reagents, dimethylsulfate (DMS) and aminomethylpsoralen, have been used to footprint the entire IRES of foot-and-mouth disease virus (FMDV) in living cells; these reagents enter the cell membrane and interact with nucleic acids in a structure-dependent manner. For FMDV, as in other picornaviruses, viral infection is dependent on the correct function of the IRES; therefore, the IRES region itself constitutes a useful target of antiviral drugs. Here, the in vivo footprint of a picornavirus IRES element in the context of a biologically active mRNA is shown for the first time. The accessibility of unpaired adenosine and cytosine nucleotides in the entire FMDV IRES was first obtained in vitro by DMS probing; subsequently, this information was used to interpret the footprint data obtained in vivo for the mRNA encompassing the IRES element in the intercistronic space. The results of DMS accessibility and UV-psoralen cross-linking studies in the competitive cellular environment provided evidence for differences in RNA structure from data obtained in vitro, and provided essential information to identify appropriate targets within the FMDV IRES aimed at combating this important pathogen.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17947530     DOI: 10.1099/vir.0.83218-0

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  8 in total

1.  Tailoring the switch from IRES-dependent to 5'-end-dependent translation with the RNase P ribozyme.

Authors:  Noemi Fernández; Encarnación Martínez-Salas
Journal:  RNA       Date:  2010-03-01       Impact factor: 4.942

Review 2.  Toward a structural understanding of IRES RNA function.

Authors:  Megan E Filbin; Jeffrey S Kieft
Journal:  Curr Opin Struct Biol       Date:  2009-04-09       Impact factor: 6.809

3.  Exploring IRES region accessibility by interference of foot-and-mouth disease virus infectivity.

Authors:  Teodoro Fajardo; Maria Flora Rosas; Francisco Sobrino; Encarnacion Martinez-Salas
Journal:  PLoS One       Date:  2012-07-18       Impact factor: 3.240

4.  In-cell SHAPE uncovers dynamic interactions between the untranslated regions of the foot-and-mouth disease virus RNA.

Authors:  Rosa Diaz-Toledano; Gloria Lozano; Encarnacion Martinez-Salas
Journal:  Nucleic Acids Res       Date:  2017-02-17       Impact factor: 16.971

5.  A novel role for Gemin5 in mRNA translation.

Authors:  Almudena Pacheco; Sonia López de Quinto; Jorge Ramajo; Noemí Fernández; Encarnación Martínez-Salas
Journal:  Nucleic Acids Res       Date:  2008-12-09       Impact factor: 16.971

6.  Targeting Highly Structured RNA by Cooperative Action of siRNAs and Helper Antisense Oligomers in Living Cells.

Authors:  Mariola Dutkiewicz; Agata Ojdowska; Jakub Kuczynski; Vanessa Lindig; Heinz Zeichhardt; Jens Kurreck; Jerzy Ciesiołka
Journal:  PLoS One       Date:  2015-08-26       Impact factor: 3.240

7.  The impact of RNA structure on picornavirus IRES activity.

Authors:  Encarnación Martínez-Salas
Journal:  Trends Microbiol       Date:  2008-04-15       Impact factor: 17.079

Review 8.  Unmasking the information encoded as structural motifs of viral RNA genomes: a potential antiviral target.

Authors:  Cristina Romero-López; Alfredo Berzal-Herranz
Journal:  Rev Med Virol       Date:  2013-08-27       Impact factor: 6.989

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.